Prawo i regulacje · 11/02/2015

INSYS Therapeutics, Inc. Files Bulk Manufacturer of Controlled Substances Application with DEA

INSYS Therapeutics, Inc. has submitted a bulk manufacturer of controlled substances application to the U.S. Drug Enforcement Administration (DEA) for approval, a necessary step to manufacture and distribute its prescription medications, including Subsys and Subsys CR, in the United States.